Empowering AI-Driven Drug Discovery: Overcoming Challenges... Marius Tanawa Tsamo & Gustav Rasmussen
Marius Tanawa Tsamo, Gustav Rasmussen
KubeCon + CloudNativeCon Europe 2025 · Session
This presentation, delivered by Gustav Rasmussen and Marius Tanawa Tsamo from Novonordisk Research and Development, delves into the critical endeavor of extending Kubernetes with advanced AI capabilities to accelerate drug discovery. Novo Nordisk, a global pharmaceutical leader specializing in treatments for diabetes, obesity, and other serious chronic diseases, faces an exponential surge in data generation. In this context, AI is not merely an advantage but a "must-win battle" to efficiently process vast datasets, unlock new insights, and ultimately bring life-changing treatments to patients faster. The talk outlines a comprehensive strategy to integrate state-of-the-art AI infrastructure, leveraging a world-class supercomputer, into their R&D operations.
AI review
This talk from Novonordisk R&D presents a robust, technical deep-dive into building a scalable AI platform for drug discovery, leveraging a world-class supercomputer and Kubernetes. The speakers, clearly deep in the trenches, detail practical solutions to real-world problems like massive container images, data gravity, and abstracting complex HPC infrastructure for domain scientists. It's a no-nonsense account of significant engineering effort, providing valuable insights for anyone tackling large-scale AI/ML in critical, data-intensive environments.